###### Strengths and limitations of this study

-   An analysis of conflict of interest reporting at medical conferences in which data collection was undertaken in 'real-time' by delegate investigators.

-   Conferences sampled spanned five medical disciplines, but may not be generalisable to all disciplines.

-   The sample of conferences and presentations was determined pragmatically, based on the investigators' academic interests, not randomly selected.

-   The study methodology did not permit an analysis of content of conflict of interest disclosure.

Introduction {#s1}
============

Conflicts of interest (COIs) can compromise the integrity and objectivity of professional opinions, distort the interpretation of clinical research and erode public trust.[@R1] Disclosure of COIs is widely promoted within academia, regarded as 'an essential, though limited' step in addressing the issue of potential bias.[@R2] It permits the recipients of medical research findings and educational presentations to consider the potential for the competing interest(s) to influence the content and tone of the presentation.

Medical conferences are common, highly influential vehicles for informing and educating health practitioners: as many as 100 000 may be held worldwide annually.[@R3] Attendance contributes substantially to continuing medical education for many delegates. Oral presentations attract large audiences, and giving an oral presentation confers academic prestige. Commercial interest and involvement in medical conferences is strong, leading to concerns that such entities may have undue influence over programme content and faculty.[@R3] In this setting, clear disclosure of COIs of presenters is important.

To date, limited research has been conducted on disclosure of COIs by speakers at medical conferences. In two disciplines, orthopaedics and oncology, COI disclosure was inconsistent[@R5] and fleeting.[@R6] We evaluated the prevalence, duration, presentation and consistency of COI disclosure in oral presentations at two international and three national conferences we attended in 2016. Our study was designed to evaluate these outcomes in 'real-time' from a delegate's perspective.

Methods {#s2}
=======

Medical conferences {#s2a}
-------------------

Four investigators conducted the assessments at five conferences in 2016: the US Endocrine Society (AG), the American College of Rheumatology (ND), the UK Continence Society (FS), the UK Congress on Obesity (AA), and Heart UK (AA). Our sample of conferences was pragmatic, being determined by our clinical or academic interests. Session attendance was also determined by investigators' interests, but all oral presentations attended were evaluated. Two conferences, those convened by the US Endocrine Society and the American College of Rheumatology, provided speakers with instructions about both the requirement for COI disclosure and its location within the presentation, the others did not. At one conference, the American College of Rheumatology, a meeting official screened presentations on site for the presence of a COI statement. Presentations were categorised as review or plenary (≥30 min), original research standard (10--15 min) or short (3 min), or other.

Data collection {#s2b}
---------------

Our study was conducted in real time. A single investigator gathered data at each conference. At each oral presentation assessed, the investigator sat with a clear, unobstructed view of the projection screen, and in a location at which the presentation was clearly audible, and completed a standardised spreadsheet (see online [supplementary appendix](#SP1){ref-type="supplementary-material"}).
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Outcomes {#s2c}
--------

Main outcomes were the presence of a COI statement, its location within the presentation and its duration of display. Duration of display of the COI was estimated by the *sotto voce* conversational recital of 'one elephant, two elephant...' for the duration of the display, where each 'elephant' approximates 1 s.[@R7]

For each presentation, we also extracted COI information from the written abstract or speaker information in the conference programme, if either was available.

We recorded whether each presenter specifically discussed any aspect of a COI disclosure. If a presenter simply stated 'These are my disclosures/conflicts of interest', we did not code it as discussing the COI. We recorded whether the tone adopted to discuss a COI was serious or jokey/dismissive, as a subjective observation. We recorded examples of noteworthy terminology used by presenters in discussing COI disclosures.

Statistics {#s2d}
----------

The composition and size of our sample of presentations were pragmatically determined by the structure of the contributing conferences and the interests of the delegate investigators. We report descriptive statistics as proportions or median (IQR). Comparisons between groups were made using the Mann-Whitney U test.

Patient involvement {#s2e}
-------------------

Patients were not involved in the design or conduct of this study.

Because ours was an observational study in public where participants are not identified, ethical approval was not required.

Results {#s3}
=======

We evaluated 201 presentations---79 reviews, 119 original research (93 standard, 26 short) and 3 patient perspectives ([table 1](#T1){ref-type="table"}). One hundred and forty-three presentations (71%) included a COI statement (range for conferences 26%--100%). For two presentations (one American College of Rheumatology, one UK Continence Society), it was not recorded whether a COI was disclosed. For three presentations (one US Endocrine Society, one UK Continence Society, one UK Congress on Obesity), duration of display of the COI statement was not recorded. Among the 141 evaluable presentations that included a COI statement, 84 (60%) disclosed at least 1 COI and 118 (84%) reported the COI on a slide that only contained the COI (range for conferences 45%--100%).

###### 

Characteristics of conferences, oral presentations and COI statements

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Conference                         COI disclosure guidance provided   Presentations assessed\   COI statement included\   COI statement on its own slide\   At least one COI disclosed\
                                                                        n                         n/n (%)                   n/n (%)                           n/n (%)
  ---------------------------------- ---------------------------------- ------------------------- ------------------------- --------------------------------- -----------------------------
  US Endocrine Society               Yes\*                              64                        54/64 (84%)               51/54† (94%)                      33/54 (61%)

  American College of Rheumatology   Yes\*‡                             45                        45/45 (100%)              45/45 (100%)                      26/44§ (59%)

  UK Continence Society              No                                 43                        31/43 (72%)               14/31† (45%)                      12/30§ (40%)

  UK Congress on Obesity             No                                 26                        7/26 (27%)                4/7¶ (57%)                        7/7 (100%)

  Heart UK                           No                                 23                        6/23 (26%)                4/6¶ (67%)                        6/6 (100%)

  **Total**                                                             **201**                   **143/201 (71%)**         **118/143 (83%)**                 **84/141 (60%)**
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*COI statement should be on second slide of presentation.

†Remaining COI statements were on title slides.

‡Meeting representative checked presentations for compliance with presence and location of COI statement.

§Not recorded for one presentation.

¶Remaining COI statements were on title slide or conclusion slide.

COI, conflict of interest.

Disclosure of COIs in oral presentations {#s3a}
----------------------------------------

[Figure 1](#F1){ref-type="fig"} shows the duration of display of slides containing the COI statements. Overall, the median (IQR) duration of display of slides containing the COI statements was 2 s (1--5). The median duration of display varied from 1.25 s to 7.5 s at individual conferences. [Figure 2](#F2){ref-type="fig"} shows the relationships between duration of display and three potential modifiers. Duration of display of the COI statement was shorter when the statement was on a specific slide, 2 s (1--3.5), n=117, than when it was on a slide containing other information, 8 s (3--17), n=23, p\<0.0001. It was similar in the presentations that disclosed at least one COI, 2 s (1--6), n=83, and the presentations that disclosed no COI, 2 s (1--4), n=55, p=0.13. It was similar in review/plenary presentations, 2 s (1--5.3), n=50, and in other presentations, 2 s (1--5.3), n=90, p=0.42.

![Duration of display of slides containing conflict of interest statements in oral presentations at medical conferences. Data are median, IQR and range. ACR, American College of Rheumatology; UKCO, UK Congress on Obesity; UKCS, UK Continence Society; US Endo Society, US Endocrine Society.](bmjopen-2017-017019f01){#F1}

![Duration of display of slides containing conflict of interest statements in oral presentations at medical conferences. Data are median, IQR and range. COI, conflict of interest.](bmjopen-2017-017019f02){#F2}

Because of the very brief duration of display of most of the COI statements, we were rarely able to accurately count the number of individual COIs disclosed, or to discern their nature or relevance. Neither were our delegate investigators able to reliably ascertain whether COI statements referred to only the presenter or to the presenter and coauthors. In 27/84 (32%) presentations that contained a COI statement and disclosed at least one COI, the speaker explicitly discussed an aspect of it. When such an explicit discussion was undertaken, its tone was dismissive or jokey in 9/27 (33%) of instances ([box](#B1){ref-type="boxed-text"}).Box 1Examples of dismissive or jokey approaches to discussing conflict of interest disclosure'\[Company X\] have funded me to do disease state talks and the creativity of the company has been appreciated.''Here are my potential conflicts of interest: I've been very bad (*pointing to list of commercial conflicts*) and very lucky (*pointing to grant funding*).''These are my disclosures, none are particularly relevant.' No explanatory statement.'Here are my conflicts. If you don't like them, I have more.''I work with a lot of companies.' Speaker claimed requirement for academic-industry 'collaboration' to 'help our patients', did not explain nature of multiple listed conflicts of interest.'I'll come back to these later,' but did not do so.

Comparison of COI statements in oral and written formats {#s3b}
--------------------------------------------------------

[Table 2](#T2){ref-type="table"} shows data on the relationships between COI statements in oral presentations and their corresponding written formats (abstracts or meeting speaker information). For 192/201 presentations, there was a corresponding written abstract and/or speaker information in either the online or hard copy conference programme. For three conferences, the UK Continence Society, the UK Congress on Obesity, and Heart UK, no COI statements were available for any of the meeting abstracts (n=93) in their written formats. Therefore, in only 99 of 192 (52%) presentations was there a COI statement in both oral and written formats. For these 99 presentations, we found discordance for the presence of a COI disclosure between the oral and written formats in 22 cases (22%) ([figure 3](#F3){ref-type="fig"}). A COI disclosure was found in the oral but not the written format in 17 of the 22 discordant cases, and in the written but not the oral format in 5 of the 22 discordant cases. The proportions of presentations discordant for the presence of a COI disclosure and of discordance attributable to absence of a COI disclosure in each format were similar at each evaluable conference.

![Discordance in the presence of COI statements between oral presentations at medical conferences and the corresponding written formats (written abstract or speaker information). No oral presentations at the other conferences had conflict of interest statements present in both oral presentations and the corresponding written formats. ACR, American College of Rheumatology; COI, conflict of interest; US Endo Society, US Endocrine Society.](bmjopen-2017-017019f03){#F3}

###### 

COI and disclosures in oral presentations and meeting programme\*

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Conference                         Oral presentations with corresponding written abstract or speaker information\   COI statement present in both oral presentation and written abstract or speaker information\
                                     N                                                                                N/N (%)
  ---------------------------------- -------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------
  US Endocrine Society               64                                                                               54/64 (84%)

  American College of Rheumatology   45                                                                               45/45 (100%)

  UK Continence Society              43                                                                               0/43 (0%)

  UK Congress on Obesity             19†                                                                              0/19 (0%)

  Heart UK                           21‡                                                                              0/21 (0%)

  **Total**                          **192**                                                                          **99/192 (52%)**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Written presentation abstract or speaker faculty information.

†For seven presentations, neither written abstract nor speaker information was available.

‡For two presentations, neither written abstract nor speaker information was available.

COI, conflict of interest.

Discussion {#s4}
==========

Main findings {#s4a}
-------------

In our sample, 29% of oral presentations at medical conferences did not include a COI statement, and therefore did not comply with recommendations that COI disclosure be undertaken in academic discourse.[@R2] When present, COI statements were often displayed too briefly to read, let alone understand. Although the duration of display of a COI statement might be influenced by time constraints for the presentation, it was similarly brief in longer review presentations and shorter original research presentations. The longer duration of display of COI statements when they were presented on slides that contained other information suggests that the other information was responsible for the longer display. Speakers seldom discussed or explained any aspect of their disclosed COIs, and sometimes adopted a dismissive or frivolous tone when doing so. COI statements were not present in 48% of the written formats corresponding to oral presentations. When COI statements were present in both oral presentations and the corresponding written formats, discordance in the presence of a COI disclosure between oral and written formats occurred in 22% of cases.

Limitations {#s4b}
-----------

Although our study assessed presentations at meetings spanning five disciplines, our results might not apply to other medical specialities. Collecting data in real time is both a strength, mimicking as closely as possible the experiences of conference delegates, and a limitation, because it precludes analysis of the nature and relevance of the COI. Data were collected for each oral presentation by a single investigator. We did not randomly select the presentations assessed, instead taking a pragmatic approach which is likely to approximate the behaviour of most conference delegates.

Context {#s4c}
-------

Our study suggests delegates at medical conferences may be unable to accurately assess the potential influence of COI on the content and conclusions of oral presentations. This could occur because COI statements may frequently be absent, displayed too briefly to be read or not discussed in the context of the material being presented. Delegates who wish to obtain information about COIs relevant to oral presentations from the corresponding written formats may be thwarted by their absence from the latter, or misled because of inaccurate or discordant disclosures. Failure to achieve adequate communication of information about COIs might impair the delegates' ability to assess the value and quality of the information contained in the presentations. A systematic review reported that patients, physicians and participants in clinical research all considered that financial COIs compromised the quality of clinical care and research.[@R8]

We found that rates of inclusion of COI statements in presentations varied among conferences: higher rates were achieved when conference organisers provided specific instructions and/or pursued policies to vet presentations for COI statements. However, these policies did not necessarily enhance the delegates' knowledge or understanding of the COIs, because the duration of display of the COI statements in presentations at those conferences was as brief as that for the COI statements in the presentations at the conferences without specific policies designed to promote inclusion of COI statements. Among conferences that did not provide instructions about COI statements, the UK Continence Society meeting achieved a higher rate of inclusion of statements. The reason for this is uncertain, but it might reflect heightened awareness of COIs arising from controversy about financial COIs over transvaginal mesh devices (personal communication, Emeritus Professor Cathryn Glazener).

We identified few studies similar to ours. However, Endo *et al* reported that only 72% of oral presentations at a dermatology conference included a COI statement, even after several strategies were applied to remind presenters of the requirement to do so.[@R9] In addition, two studies reported display times of 3 and 5 s, respectively, for slides containing COI information at orthopaedic and oncology meetings, respectively.[@R6] Finally, 9% of presenters who gave oral presentations at each of two conferences on arthroplasty in the same calendar year disclosed financial COIs at one meeting but not the other.[@R11] Each of these results is broadly consistent with our findings, and suggests that the results we report apply generally across conferences in medical disciplines other than those we assessed.

Conclusions and implications {#s5}
============================

Our study suggests that management of COI at medical meetings may be suboptimal. To avoid paying lip service to COIs in conference presentations, improvements could be made in several areas and both conference organisers and presenters can contribute. Disclosure statements should be required and their presence audited. Efforts to standardise the content and focus of COI statements, such as those initiated by the Institute of Medicine,[@R12] should be supported and applied by conference organisers. COI statements by presenters should be displayed long enough to permit understanding, and their relevance adequately discussed. Innovative strategies such as displaying COI statements during question time, or having the session chairperson include a COI statement as part of the introduction of the presentation, could be trialled. Finally, presenters should explain any discordance between the contents of disclosures in oral and written formats.
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